SG170061A1 - Biomarkers useful for diagnosing prostate cancer, and methods thereof - Google Patents

Biomarkers useful for diagnosing prostate cancer, and methods thereof

Info

Publication number
SG170061A1
SG170061A1 SG201101506-2A SG2011015062A SG170061A1 SG 170061 A1 SG170061 A1 SG 170061A1 SG 2011015062 A SG2011015062 A SG 2011015062A SG 170061 A1 SG170061 A1 SG 170061A1
Authority
SG
Singapore
Prior art keywords
prostate cancer
intensities
methods
diagnosing prostate
biomarkers useful
Prior art date
Application number
SG201101506-2A
Other languages
English (en)
Inventor
Shawn Ritchie
Erin Bingham
Original Assignee
Phenomenome Discoveries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phenomenome Discoveries Inc filed Critical Phenomenome Discoveries Inc
Publication of SG170061A1 publication Critical patent/SG170061A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G01N2405/04—Phospholipids, i.e. phosphoglycerides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/72—Mass spectrometers
    • G01N30/7233—Mass spectrometers interfaced to liquid or supercritical fluid chromatograph

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Ecology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electrochemistry (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SG201101506-2A 2006-03-24 2007-03-23 Biomarkers useful for diagnosing prostate cancer, and methods thereof SG170061A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78548006P 2006-03-24 2006-03-24

Publications (1)

Publication Number Publication Date
SG170061A1 true SG170061A1 (en) 2011-04-29

Family

ID=38540744

Family Applications (1)

Application Number Title Priority Date Filing Date
SG201101506-2A SG170061A1 (en) 2006-03-24 2007-03-23 Biomarkers useful for diagnosing prostate cancer, and methods thereof

Country Status (10)

Country Link
US (2) US8409794B2 (fr)
EP (2) EP2674435A3 (fr)
JP (2) JP5612303B2 (fr)
KR (1) KR20090006837A (fr)
CN (1) CN101454331A (fr)
AU (1) AU2007231487B2 (fr)
BR (1) BRPI0709176A2 (fr)
CA (1) CA2644330C (fr)
SG (1) SG170061A1 (fr)
WO (1) WO2007109881A1 (fr)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060078893A1 (en) 2004-10-12 2006-04-13 Medical Research Council Compartmentalised combinatorial chemistry by microfluidic control
GB0307403D0 (en) 2003-03-31 2003-05-07 Medical Res Council Selection by compartmentalised screening
GB0307428D0 (en) 2003-03-31 2003-05-07 Medical Res Council Compartmentalised combinatorial chemistry
US20050221339A1 (en) 2004-03-31 2005-10-06 Medical Research Council Harvard University Compartmentalised screening by microfluidic control
US7968287B2 (en) 2004-10-08 2011-06-28 Medical Research Council Harvard University In vitro evolution in microfluidic systems
JP2009536313A (ja) 2006-01-11 2009-10-08 レインダンス テクノロジーズ， インコーポレイテッド ナノリアクターの形成および制御において使用するマイクロ流体デバイスおよび方法
US20080014589A1 (en) 2006-05-11 2008-01-17 Link Darren R Microfluidic devices and methods of use thereof
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
US9012390B2 (en) 2006-08-07 2015-04-21 Raindance Technologies, Inc. Fluorocarbon emulsion stabilizing surfactants
US20090075284A1 (en) * 2006-09-19 2009-03-19 The Regents Of The University Of Michigan Metabolomic profiling of prostate cancer
EP2560006A3 (fr) * 2006-09-19 2013-06-12 Metabolon Inc. Biomarqueurs pour le cancer de la prostate et procédés les utilisant
KR101542037B1 (ko) * 2006-12-21 2015-08-05 아지노모토 가부시키가이샤 암 상태의 평가 방법, 및 암 평가 장치, 암 평가 방법, 암 평가 시스템, 암 평가 프로그램 및 기록 매체
US8772046B2 (en) 2007-02-06 2014-07-08 Brandeis University Manipulation of fluids and reactions in microfluidic systems
US8592221B2 (en) 2007-04-19 2013-11-26 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
US20100291690A1 (en) * 2007-11-07 2010-11-18 Lian Shan Methods for detecting or monitoring cancer using lpc as a marker
WO2009061412A1 (fr) * 2007-11-07 2009-05-14 Frantz Biomarkers, Llc Procédés pour détecteur ou surveiller un cancer à l'aide de lpe en tant que marqueur
WO2009086297A2 (fr) * 2007-12-21 2009-07-09 The Board Of Regents Of The University Of Oklahoma Identification de marqueurs biologiques dans des échantillons biologiques et leurs procédés d'utilisation
CN101960310A (zh) * 2008-03-04 2011-01-26 味之素株式会社 癌症种类的评价方法
CN102066946B (zh) * 2008-06-20 2016-08-31 味之素株式会社 前列腺疾病的评价方法
AU2009270851A1 (en) * 2008-07-16 2010-01-21 Dana-Farber Cancer Institute, Inc. Signatures and PCDETERMINANTS associated with prostate cancer and methods of use thereof
US12038438B2 (en) 2008-07-18 2024-07-16 Bio-Rad Laboratories, Inc. Enzyme quantification
WO2010009365A1 (fr) 2008-07-18 2010-01-21 Raindance Technologies, Inc. Bibliothèque de gouttelettes
KR101018665B1 (ko) 2008-08-18 2011-03-04 재단법인서울대학교산학협력재단 전립선암 진단 방법 및 장치
US8399829B2 (en) 2008-12-18 2013-03-19 Quest Diagnostics Investments Incorporated Vitamin B2 detection by mass spectrometry
US8528589B2 (en) 2009-03-23 2013-09-10 Raindance Technologies, Inc. Manipulation of microfluidic droplets
US9500572B2 (en) 2009-04-30 2016-11-22 Purdue Research Foundation Sample dispenser including an internal standard and methods of use thereof
US20120122243A1 (en) * 2009-06-04 2012-05-17 Charite Universitatsmedizin Berlin Means and method and means for diagnosing prostate carcinomas
SG179122A1 (en) * 2009-10-01 2012-05-30 Phenomenome Discoveries Inc Serum-based biomarkers of pancreatic cancer and uses thereof for disease detection and diagnosis
WO2011042564A1 (fr) 2009-10-09 2011-04-14 Universite De Strasbourg Nanomatériau marqué à base de silice à propriétés améliorées et ses utilisations
WO2011087845A2 (fr) * 2009-12-22 2011-07-21 The Regents Of The University Of Michigan Profilage métabolomique du cancer de la prostate
US10837883B2 (en) 2009-12-23 2020-11-17 Bio-Rad Laboratories, Inc. Microfluidic systems and methods for reducing the exchange of molecules between droplets
EP2354794A1 (fr) * 2010-01-29 2011-08-10 IMG Institut für medizinische Genomforschung Planungsgesellschaft M.B.H. Diagnostic de la rechute du cancer de la prostate
WO2011100604A2 (fr) 2010-02-12 2011-08-18 Raindance Technologies, Inc. Analyse numérique d'analytes
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
US9399797B2 (en) 2010-02-12 2016-07-26 Raindance Technologies, Inc. Digital analyte analysis
CN103038857B (zh) * 2010-05-07 2016-01-20 Ut-巴特勒有限责任公司 从表面提取样品的系统和方法
US20130109592A1 (en) * 2010-06-23 2013-05-02 University Of Louisville Research Foundation, Inc. Methods for detecting cancer
CA2807811A1 (fr) * 2010-07-28 2012-02-02 Metabolon Inc. Biomarqueurs du cancer de la prostate et procedes les utilisant
US9562897B2 (en) 2010-09-30 2017-02-07 Raindance Technologies, Inc. Sandwich assays in droplets
US9364803B2 (en) 2011-02-11 2016-06-14 Raindance Technologies, Inc. Methods for forming mixed droplets
EP3736281A1 (fr) 2011-02-18 2020-11-11 Bio-Rad Laboratories, Inc. Compositions et méthodes de marquage moléculaire
EP2714970B1 (fr) 2011-06-02 2017-04-19 Raindance Technologies, Inc. Quantification d'enzyme
US8841071B2 (en) 2011-06-02 2014-09-23 Raindance Technologies, Inc. Sample multiplexing
US8658430B2 (en) 2011-07-20 2014-02-25 Raindance Technologies, Inc. Manipulating droplet size
EP2823303A4 (fr) 2012-02-10 2015-09-30 Raindance Technologies Inc Dosage de type criblage diagnostique moléculaire
EP2823427B1 (fr) 2012-03-05 2020-12-16 OY Arctic Partners AB Systèmes informatiques, procédés et support de stockage lisible par ordinateur pour prédire le risque de volume de la glande prostatique
WO2013165748A1 (fr) 2012-04-30 2013-11-07 Raindance Technologies, Inc Analyse d'analyte numérique
US20150285805A1 (en) 2012-11-05 2015-10-08 Ospedale San Raffaele S.R.L. Biomarkers of multiple myeloma development and progression
US9176154B2 (en) * 2012-12-12 2015-11-03 Bio-Rad Laboratories, Inc. Calibration process and system
CA2888351A1 (fr) 2013-01-31 2014-08-07 Purdue Research Foundation Methodes d'analyse de petrole brut
WO2014120411A1 (fr) * 2013-01-31 2014-08-07 Purdue Research Foundation Systèmes et procédés pour analyser un échantillon extrait
EP2986762B1 (fr) 2013-04-19 2019-11-06 Bio-Rad Laboratories, Inc. Analyse d'analyte numérique
TR201906195T4 (tr) * 2013-05-14 2019-05-21 Centogene Ag Niemann pıck hastalığının teşhisi için metot.
EP3486937B1 (fr) 2013-06-25 2022-07-27 Purdue Research Foundation Analyse par spectrométrie de masse de micro-organismes dans des échantillons
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US9944977B2 (en) 2013-12-12 2018-04-17 Raindance Technologies, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
US11193176B2 (en) 2013-12-31 2021-12-07 Bio-Rad Laboratories, Inc. Method for detecting and quantifying latent retroviral RNA species
CN114740202A (zh) 2014-03-28 2022-07-12 欧普科诊断有限责任公司 与前列腺癌的诊断有关的组合物和方法
US10879056B2 (en) 2014-05-30 2020-12-29 ASTA, Co. Ltd Integrated disease diagnostic system using matrix-assisted laser desorption/ionization time-of-flight mass spectrometer
US10197551B2 (en) * 2014-05-30 2019-02-05 ASTA, Co. Ltd. Integrated disease diagnostic system using matrix-assisted laser desorption/ionization time-of-flight mass spectrometer
US9786478B2 (en) 2014-12-05 2017-10-10 Purdue Research Foundation Zero voltage mass spectrometry probes and systems
JP6948266B2 (ja) 2015-02-06 2021-10-13 パーデュー・リサーチ・ファウンデーションＰｕｒｄｕｅ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ プローブ、システム、カートリッジ、およびその使用方法
WO2016160545A1 (fr) 2015-03-27 2016-10-06 Opko Diagnostics, Llc Standards d'antigènes prostatiques et utilisations
US10647981B1 (en) 2015-09-08 2020-05-12 Bio-Rad Laboratories, Inc. Nucleic acid library generation methods and compositions
CN105424841B (zh) * 2015-12-25 2017-11-03 齐炼文 用于诊断冠状动脉粥样硬化的代谢标志物
JP2017203649A (ja) * 2016-05-09 2017-11-16 国立大学法人大阪大学 前立腺がん判定方法
US10006925B2 (en) 2016-05-30 2018-06-26 Universal Diagnostics, S. L. Methods and systems for metabolite and/or lipid-based detection of colorectal cancer and/or adenomatous polyps
JP7549306B2 (ja) * 2016-07-22 2024-09-11 株式会社リピドームラボ 新規リン脂質およびその利用ならびにリン脂質分離測定法の開発
US10319574B2 (en) * 2016-08-22 2019-06-11 Highland Innovations Inc. Categorization data manipulation using a matrix-assisted laser desorption/ionization time-of-flight mass spectrometer
US11073522B2 (en) 2016-10-03 2021-07-27 Lincoln Memorial University Structural validation of very long chain dicarboxylic acids
WO2018158801A1 (fr) * 2017-02-28 2018-09-07 株式会社島津製作所 Dispositif et procédé d'extraction de caractéristiques de données spectrales
US10998178B2 (en) 2017-08-28 2021-05-04 Purdue Research Foundation Systems and methods for sample analysis using swabs

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4813171A (en) 1987-11-24 1989-03-21 Herbert Cooper Power-operated lateral actuator for a fishing outrigger
US4953328A (en) 1989-05-24 1990-09-04 Sewell Scott R Air conditioning compressor sectionalized cover
AT399867B (de) 1990-01-11 1995-08-25 Lisec Peter Anlage zur herstellung von isolierglasscheiben
US5233640A (en) 1991-01-11 1993-08-03 Detection Systems, Inc. Security system with backup dialer
IT1252437B (it) 1991-07-19 1995-06-14 Gd Spa Metodo e dispositivo per la piegatura di sbozzati di incarto lungo linee di piegatura pre-indebolite
CA2089503C (fr) 1992-02-19 1996-09-03 Marcus Mintz Confection de conditionnement de produits de viande
US5213480A (en) 1992-06-08 1993-05-25 Graco, Inc. Pump lift mechanism
US5313123A (en) 1992-11-23 1994-05-17 Leonid Simuni Automobile having the magnetohydrodynamic engine
DE4306614A1 (de) 1993-03-03 1994-09-08 Bayer Ag Verfahren zur Wiederverwertung von Lackabfällen
US5441589A (en) 1993-06-17 1995-08-15 Taurus Impressions, Inc. Flat bed daisy wheel hot debossing stamper
JPH08505510A (ja) 1993-10-28 1996-06-11 モトローラ・インコーポレーテッド 複数のデータプロトコルに適用可能な復調器論理ユニット
US5434195A (en) 1994-06-23 1995-07-18 The Dow Chemical Company Extruded, open-cell alkenyl aromatic polymer foam and process for making
US5653394A (en) 1995-09-28 1997-08-05 Highline Mfg. Inc. Disintegration of baled crop materials
US5673546A (en) 1995-12-26 1997-10-07 Abraham; Carl J. Non-slip shoelaces
US5858681A (en) 1996-06-17 1999-01-12 Children's Medical Center Method for prognosis of prostate cancer
JP2002510386A (ja) * 1997-03-21 2002-04-02 アタイアジン テクノロジーズ，インコーポレーテッド リゾリン脂質の濃度変化に関連する癌の検出方法
CA2386669A1 (fr) 1999-10-07 2001-04-12 Ciphergen Biosystems, Inc. Proteines marqueur du cancer de la prostate
CA2298181C (fr) 2000-02-02 2006-09-19 Dayan Burke Goodnough Analyse d'echantillons complexes non-cibles
AU2001249275B2 (en) 2000-03-20 2005-12-08 Eastern Virginia Medical School Prostate cancer markers
JP2003530130A (ja) * 2000-04-14 2003-10-14 メタボロン インコーポレイテッド メタボロミクスを使用した薬物発見、疾患の処置、及び診断のための方法
WO2002044417A2 (fr) 2000-11-28 2002-06-06 Wyeth Analyse d'expression d'acides nucleiques et de polypeptides d'inhibiteurs de differenciation utile dans le diagnostic et le traitement du cancer de la prostate
US20030228639A1 (en) * 2001-03-19 2003-12-11 Wright George L Prostate cancer markers
US6919176B2 (en) * 2001-05-07 2005-07-19 Amgen Inc. Polypeptides and nucleic acids associated with cancer
JP2004530884A (ja) * 2001-05-25 2004-10-07 マウント・シナイ・ホスピタル Ｅｐｈｂ２のキナーゼドメインを調節する方法
EP1549938A4 (fr) 2002-04-26 2010-05-12 Univ Johns Hopkins Identification de marqueurs biologiques pour la detection du cancer de la prostate
US20060088894A1 (en) * 2002-05-10 2006-04-27 Eastern Virginia Medical School Prostate cancer biomarkers
AUPS282602A0 (en) * 2002-06-07 2002-06-27 Garvan Institute Of Medical Research Method of inhibiting cell proliferation
US20050244973A1 (en) * 2004-04-29 2005-11-03 Predicant Biosciences, Inc. Biological patterns for diagnosis and treatment of cancer
US20070009970A1 (en) * 2005-07-08 2007-01-11 Predicant Biosciences, Inc. Biological patterns for diagnosis and treatment of cancer

Also Published As

Publication number Publication date
CA2644330A1 (fr) 2007-10-04
JP2013092527A (ja) 2013-05-16
EP1922326A1 (fr) 2008-05-21
EP1922326A4 (fr) 2011-06-01
JP5612303B2 (ja) 2014-10-22
CN101454331A (zh) 2009-06-10
US8409794B2 (en) 2013-04-02
JP5502972B2 (ja) 2014-05-28
KR20090006837A (ko) 2009-01-15
WO2007109881A9 (fr) 2008-10-30
BRPI0709176A2 (pt) 2011-06-28
US20090127454A1 (en) 2009-05-21
EP2674435A3 (fr) 2014-04-30
EP2674435A2 (fr) 2013-12-18
WO2007109881A8 (fr) 2007-12-13
AU2007231487A1 (en) 2007-10-04
WO2007109881A1 (fr) 2007-10-04
AU2007231487B2 (en) 2014-01-09
US20130330746A1 (en) 2013-12-12
CA2644330C (fr) 2012-05-01
JP2009530624A (ja) 2009-08-27

Similar Documents

Publication Publication Date Title
SG170061A1 (en) Biomarkers useful for diagnosing prostate cancer, and methods thereof
MY184498A (en) Methods for the diagnosis of ovarian cancer health states and risk of ovarian cancer health states
MX357119B (es) Microarn plasmáticos para la detección de cáncer colorrectal temprano.
MX2007004176A (es) B7-h1 y metodos de diagnosis, prognosis, y tratamiento de cancer.
EP2829881A3 (fr) Diagnostic de cancer colorectal
NZ628281A (en) Biomarkers for the diagnosis and/or prediction of susceptibility to mental and neurodegenerative disorders
EP2566983A4 (fr) Analyse en série de biomarqueurs à des fins de diagnostic d'une maladie
NZ597363A (en) Prognosis prediction for colorectal cancer
EP4282405A3 (fr) Détection de biomarqueurs du cancer à l'aide de nanoparticules
MX2019003811A (es) Metodos para predecir el desenlace clinico del cancer.
WO2009040782A3 (fr) Procédé d'évaluation de l'état de cancer colorectal chez un individu
WO2006089212A3 (fr) Cyr61 comme biomarqueur pour le diagnostic et le pronostic de cancers d'origine epitheliale
WO2005041893A3 (fr) Detection des biomarqueurs de l'infarctus aigu du myocarde
IL204922A0 (en) Methods for detecting major adverse cardiovascular and cerebrovascular events
WO2005103719A3 (fr) Utilisation de motif proteomique de plasma aux fins de diagnostic, classification, prevision de reponse a un traitement et un comportement clinique, stratification de traitement et surveillance de la maladie dans le cas de malignites hematologiques
WO2005042761A3 (fr) Biomarqueurs de la sclerose laterale amyotrophique
WO2004090550A3 (fr) Procede de detection d'un cancer colorectal dans des echantillons humains
HK1118095A1 (en) Annexin for cancer risk assessment
SG179122A1 (en) Serum-based biomarkers of pancreatic cancer and uses thereof for disease detection and diagnosis
WO2010051314A3 (fr) Classification génomique de carcinomes pulmonaires non à petites cellules en fonction de profils d'altérations du nombre de copies de gènes
MX2015013415A (es) Metodo y sistema para analizar especímenes biológicos mediante formación de imágenes espectrales.
GB201222576D0 (en) Method for diagnosing lung cancer
WO2007126901A3 (fr) Appareil et procédé destinés à prévenir des maladies
WO2004007770A3 (fr) Procede de diagnostic de tumeurs gastriques de type intestinal
EP2415877A3 (fr) Moyens et procédés pour diagnostiquer un cancer pancréatique